Heraeus Medical Expands Strategic Business Unit with Resorbable Biomaterials for Use in Regenerative Orthopedics – Launch of “heracure” at DKOU 2025

Products

Corporate

With the acquisition of INNOTERE GmbH, Heraeus Medical, a leading manufacturer of bone cements and biomaterials for orthopedics and trauma surgery, expands its existing business and adds resorbable biomaterials for bone regeneration to its product portfolio.

The newly introduced brand by Heraeus Medical named “heracure” currently comprises two products: heracure one and heracure 3D. Both products will be presented for the first time by Heraeus Medical at the DKOU 2025 in Berlin at the Heraeus Medical company booth.

These products are innovative calcium phosphate-based biomaterials for bone substitution, which can be applied or filled into existing non-infected and non-load-bearing bone defects. The lead product, heracure one, is a paste pre-filled in an application syringe and ready to use without any additional preparation steps. heracure 3D are small-sized shaped bodies of various sizes and designs, based on the heracure one paste and produced through a patented 3D printing process. Both products are fully MDR-certified.

The products are developed and manufactured by INNOTERE GmbH, based in Radebeul, Germany. The integration of INNOTERE into Heraeus Medical GmbH began at the start of 2025 and has consecutively been completed in the last months. INNOTERE will continue to operate from its location in Radebeul.

With INNOTERE, we have found an ideal platform to continue our growth trajectory, whose high-quality, innovative product portfolio meets the essential needs of today’s orthopedic patients and supports individualized therapy approaches. By complementing our proven product portfolio — bone cements for arthroplasty surgery — with the new product segment of resorbable biomaterials, we underscore our commitment to developing pioneering products that enable excellent treatment outcomes and foster growth in key therapeutic areas. Above all, we are delighted to welcome the entire INNOTERE team — highly skilled experts with extensive know-how in resorbable biomaterials — who will enrich Heraeus Medical’s innovative strength. For the future, our joint goal with INNOTERE is to strengthen our competence and knowledge in the field of resorbable materials and to continuously expand our expertise in this area.

Andrew Williamson

Co-President

Heraeus Medical

We at INNOTERE are also very excited about the partnership we have joined with Heraeus Medical and look forward with great anticipation to the future paths we can now take together to improve therapy options in orthopedics and traumatology in the long term. Heraeus Medical’s strong expertise in the training and education of orthopaedic surgeons, its extensive sales structure, and established market position make the company the ideal partner for INNOTERE to grow together and actively shape the development of innovative medical products for regenerative orthopedics.

Sascha Heinemann

Managing Director

INNOTERE

Further information on the availability of heracure will be announced in due course.

heracure at DKOU 2025

heracure one and heracure 3D will be presented under the new brand name for the first time by Heraeus Medical at DKOU 2025 in Berlin at the Heraeus Medical company booth.

Visit us at booth B93, Level 2.

Andrea Pansegrau

Press Contact

Send Mail

+49 6181 35-2504

Heraeus Medical GmbHPhilipp-Reis-Str. 8/1361273 WehrheimGermany